ERBB2 and breast cancer: Therefore, it must be emphasized that a “favorable” C allele-containing rs11212617 genotype –an allele previously associated with treatment success on metformin in T2D patients (Figure 1) – is a predictor for achieving pCR in non-diabetic HER2+ BC patients.